| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9005686 | Clinical Therapeutics | 2005 | 12 Pages |
Abstract
BIAsp 30 plus pioglitazone provided an efficacious and well-tolerated treatment alternative to glibenclamide plus pioglitazone or BIAsp 30 alone in this population of patients who previously were not well controlled on glibenclamide monotherapy or combination therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
MD Raz, MD Stranks, MD Filipczak, MD Joshi, MD Lertoft, BSc Rastam, MD Chow, MD Shaban,